Dr. Douglas Harrington has over 30 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. As former President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings.
Dr. Harrington holds a number of patents including automated image analysis of residual cancer protein, catalytic heavy metal extraction, and biomarker assays for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies – from devices to molecular genetics focusing on immunology, cancer and cardiology, where he has taken a number of new molecular technologies through state and federal regulatory approval.
Don't miss out on more Redefining Medicine podcast - Subscribe today and say hello to us on social media! Email us at [email protected]
The views and opinions expressed on this program are those of the persons appearing on the program and do not necessarily reflect the views and opinions of The American Academy of Anti-Aging Medicine A4M/MMI™